J Clin Oncol
Antineoplastic Combined Chemotherapy ProtocolsBenzimidazolesCytarabine
Dr. Chatchada Karanes, MD
NPI1700993599
- Medicare services, 2021
- 203
- Part D claims, 2021
- 112
- Publications
- 107
- Clinical trials
- 15
- Industry payments
- $11,421
- Practice address
- 1500 Duarte Rd, Duarte, CA 91010
- Practice phone
- Call (800) 826-4673
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
City of Hope - Main Campus (Duarte)
Duarte, California
Find Dr. Karanes' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Chatchada Karanes is a hematology (internal medicine) physician in Duarte, California
Dr. Karanes practices at City of Hope - Main Campus (Duarte) in Duarte, California.
Dr. Karanes' NPI, 1700993599, was assigned on August 25, 2006. Dr. Karanes graduated from Mahidol University Faculty of Medicine in 1971. Dr. Karanes holds California license C51816.
NPI and contact details
- NPI
- 1700993599NPI Registry (opens in a new tab)
- NPI enumeration date
- August 25, 2006
- NPI status
- Active
- Practice phone
- (800) 826-4673
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1971
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Chatchada Karanes practices at City of Hope - Main Campus (Duarte) in Duarte, California
Dr. Karanes' primary practice is City of Hope - Main Campus (Duarte), at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.
- City of Hope - Main Campus (Duarte)1500 Duarte Rd, Duarte, CA 91010 · Los Angeles CountyPhone(800) 826-4673
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Chatchada Karanes is affiliated with 1 site of care
Dr. Karanes' primary practice is City of Hope - Main Campus (Duarte) in Duarte, California.
City of Hope - Main Campus (Duarte)Primary
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Chatchada Karanes' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Karanes practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| City of Hope - Main Campus (Duarte) | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Karanes practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Chatchada Karanes is one of 153 hematology (internal medicine) physicians in California
Internal medicine is Dr. Karanes' primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Karanes is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Karanes' licenses on file in 4 states: California, Illinois, Minnesota and Michigan.
Specialties and state licenses
- Hematology (internal medicine), CaliforniaPrimary
- Illinois license
- Minnesota license
- Michigan license
Hematology (internal medicine) physicians near Dr. Karanes
Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.
153hematology (internal medicine) physicians in California54hematology (internal medicine) physicians in Duarte
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Chatchada Karanes billed Medicare for 203 services in 2021
CMS data shows 203 Medicare services from Dr. Karanes across 2 procedure codes in 2021. Medicare paid $16,636 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2021203
Paid by Medicare$16,636
Procedure codes2
Dr. Karanes' Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 1,0012021: 20380%
Dr. Karanes compared with the California median for hematology (internal medicine) physicians, 2021
- Dr. Karanes
- California median
- Medicare services
- 203vs 37346% below
- Part D claims
- 112vs 9913% above
Medians across 139 hematology (internal medicine) physicians in California with Dmand AI profiles that report each measure.
Dr. Karanes' most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Karanes?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Karanes and other hematology (internal medicine) physicians in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Chatchada Karanes' patients have a median age of 66
Across all payers, Dmand AI patient panel data puts Dr. Karanes' median patient age at 66, with 50% women.
Dr. Karanes' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 66
Patient panel by sex, all payers
- Women50%
- Men50%
Source: Dmand AI Patient Panel Data
Dr. Chatchada Karanes wrote 112 Medicare Part D claims in 2021
In 2021, Dr. Karanes wrote 112 Medicare Part D claims. Every claim was for a generic drug. They cover 6 drugs, with $1,118,801 in total drug cost. In 2020, CMS named 557 claims across 20 drugs.
Part D claims, 2021112
Drugs named by CMS6
Total drug cost$1.1M
Dr. Karanes' most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 5572021: 11280%
Drugs named by CMS: 6 in 2021, 20 in 2020.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematology (internal medicine) physicians like Dr. Karanes by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Chatchada Karanes has 107 publications on record
Dmand AI links 107 papers to Dr. Karanes, published from 2001 to 2024. 2020 was the busiest year, with 11. The most frequent topics are Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation and Transplantation, Homologous. Dr. Karanes has published most often in Bone Marrow Transplant. Dr. Karanes' most frequent co-authors are Stephen J. Forman, MD, Ryotaro Nakamura, MD and Ayad M. Al-Katib, MD.
Papers107
Years published2001 to 2024
Dr. Karanes' papers by year, 2015 to 2024
Topics Dr. Karanes writes about most
- Bone Marrow Transplantation
- Hematopoietic Stem Cell Transplantation
- Transplantation, Homologous
- Antineoplastic Combined Chemotherapy Protocols
- Transplantation, Autologous
- Graft vs Host Disease
- Transplantation Conditioning
- Multiple Myeloma
Dr. Karanes' most frequent co-authors
- Stephen J. Forman, MD15 shared papers
- Ryotaro Nakamura, MD10 shared papers
- Ayad M. Al-Katib, MD8 shared papers
Recent publications by Dr. Karanes
N Engl J Med
Administration, OralAntibodiesAntineoplastic Agents
Anemia, AplasticBone Marrow TransplantationCyclophosphamide
Bone MarrowHematopoietic Stem Cell TransplantationTransplantation Conditioning
Cord Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation Conditioning
See who Dr. Karanes researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Karanes works with, so you can find a warm path to the right hematology (internal medicine) physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Chatchada Karanes has worked on 15 clinical trials
Dmand AI links Dr. Karanes to 15 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Myelodysplastic Syndromes. Arog Pharmaceuticals, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Karanes that name 2 trials.
Clinical trials with Dr. Karanes by phase
- 2Phase 1: 2 trials
- 3Phase 1/2: 3 trials
- 5Phase 2: 5 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Karanes' trials
- Multiple Myeloma
- Blood Protein Disorders
- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
- Anemia, Aplastic
Investigators on the most trials with Dr. Karanes
- Mhd Monzr Al Malki, MD5 shared trials
- Jonathan A. Gutman, MD5 shared trials
- Juliet N. Barker, MBBS4 shared trials
Recent clinical trials with Dr. Karanes
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma (opens in a new tab)
SuspendedPhase 1/2
Multiple MyelomaBlood Protein DisordersNEXI-002 T Cells
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT (opens in a new tab)
Active, not recruitingPhase 1/2
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteInfusion of NEXI-001 T Cells
Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML (opens in a new tab)
Status unknownPhase 3
CrenolanibMidostaurinCytarabine
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML (opens in a new tab)
Status unknownPhase 3
Disease AttributesPathological Conditions, Signs and SymptomsCrenolanibCytarabineFludarabine
Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation (opens in a new tab)
CompletedPhase 1
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteAB-110Unmanipulated Umbilical Cord Blood (UCB)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Chatchada Karanes received $11,421 in industry payments from 2016 to 2022
CMS Open Payments shows 62 general payments to Dr. Karanes from 11 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 50% of the total. Pharmacyclics LLC, An AbbVie Company paid the most, $5,891. It also lists 16 research payments totaling $11,952 from 2018 to 2022, naming 2 clinical trials.
General payments to Dr. Karanes by program year, 2016 to 2022
General payments to Dr. Karanes by kind, 2016 to 2022
$11.4Kin total
- Consulting fees$5,65750%
- Travel and lodging$2,16719%
- Speaker and faculty fees$2,02818%
- Food and beverage$1,56914%
Companies that paid Dr. Karanes the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Chatchada Karanes graduated from Mahidol University Faculty of Medicine
Dr. Karanes graduated from Mahidol University Faculty of Medicine in 1971. Dr. Karanes is a member of ASCO.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Chatchada Karanes accepts plans from 3 insurance carriers
Dr. Karanes is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, Elevance and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Massachusetts
- Elevance
- HCSC
Plan types Dr. Karanes accepts, by number of carriers
- Medicare3
- PPO3
Source: Dmand AI Insurance Network Data
Sources for Dr. Chatchada Karanes's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Chatchada Karanes
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Chatchada Karanes' NPI number?
Dr. Chatchada Karanes' NPI number is 1700993599. It was assigned on August 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Chatchada Karanes?
Dr. Chatchada Karanes is a hematology (internal medicine) physician in Duarte, California. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).
Where does Dr. Chatchada Karanes practice?
Dr. Karanes practices at 1500 Duarte Rd, Duarte, CA 91010. Dr. Karanes' primary practice is City of Hope - Main Campus (Duarte) in Duarte, California.
What is Dr. Chatchada Karanes' office phone number?
The practice phone on file for Dr. Karanes is (800) 826-4673.
What is Dr. Chatchada Karanes' medical license number?
Dr. Karanes holds California license C51816, one of the licenses on file in 4 states.
Which states has Dr. Chatchada Karanes been licensed in?
Dmand AI has state licenses on file for Dr. Karanes in California (2004 to 2026), Illinois (since 1975), Minnesota (2001 to 2005) and Michigan (1979 to 2002).
Does Dr. Chatchada Karanes accept Medicare?
Yes. CMS data shows Dr. Karanes billed Medicare for 203 services in 2021.
Is Dr. Chatchada Karanes board certified?
Yes. Dr. Karanes is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Chatchada Karanes bill to Medicare?
In 2021, Dr. Karanes' most billed Medicare services were hospital inpatient care (99233) and office visit, established patient (99214).
Where did Dr. Chatchada Karanes go to medical school?
Dr. Karanes graduated from Mahidol University Faculty of Medicine in 1971.
Show 6 more questionsShow fewer questions
What drugs does Dr. Chatchada Karanes prescribe most?
In 2021 Medicare Part D data, Dr. Karanes' most prescribed drugs by claims were Revlimid, Prednisone and Acyclovir.
Has Dr. Chatchada Karanes received payments from drug or device companies?
CMS Open Payments shows $11,421 in general payments to Dr. Karanes from 11 companies from 2016 to 2022. The largest total came from Pharmacyclics LLC, An AbbVie Company.
How long has Dr. Chatchada Karanes been practicing?
Dr. Karanes graduated from medical school in 1971, 55 years ago.
Does Dr. Chatchada Karanes do research?
Dmand AI links 107 publications to Dr. Karanes, published from 2001 to 2024. Dr. Karanes has worked on 15 clinical trials.
Who does Dr. Chatchada Karanes publish with?
Dr. Karanes' most frequent co-authors are Stephen J. Forman, MD (15 shared papers), Ryotaro Nakamura, MD (10 shared papers) and Ayad M. Al-Katib, MD (8 shared papers).
What insurance does Dr. Chatchada Karanes accept?
Dr. Karanes is in network with 3 carriers, including Blue Cross Blue Shield of Massachusetts, Elevance and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to internal medicine practices?
See hematology (internal medicine) physicians in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card